Health Care · Biotechnology
Market capitalization divided by trailing twelve-month revenue. A valuation metric often used when earnings are negative or not meaningful.
Latest P/S Ratio
49.00x
As of Dec 29, 2023
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Dec 29, 2023 | 49.00x |
| Dec 28, 2023 | 47.35x |
| Dec 27, 2023 | 52.70x |
| Dec 26, 2023 | 52.10x |
| Dec 22, 2023 | 53.59x |
| Dec 21, 2023 | 54.80x |
| Dec 20, 2023 | 57.62x |
| Dec 19, 2023 | 66.07x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison